Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Fundamental Analysis of Bal Pharma Ltd

About the Company - Bal Pharma Ltd

Bal Pharma Ltd. is a Public Limited Listed company incorporated on 19/05/1987 and has its registered office in the State of Karnataka, India. Company’s Corporate Identification Number(CIN) is L85110KA1987PLC008368 and registration number is 008368. Currently company belongs to the Industry of Pharmaceuticals. Company’s Total Operating Revenue is Rs. 280.37 Cr. and Equity Capital is Rs. 14.82 Cr. for the Year ended 31/03/2022.
Pharmaceuticals# 21 & 22, Bommasandra Industrial Area, Bengaluru Karnataka
NamePosition Held
Mr. Shailesh D SiroyaManaging Director
Mr. Himesh VirupakshayaExecutive Director
Mr. Jatish ShethIndependent Director
Dr. C V SrinivasIndependent Director
Ms. Nicloa NeeladriIndependent Director
Mr. H S VenkateshAdditional Director
Mr. Kotian Chittananda DamodarAdditional Director

Bal Pharma Ltd. Share Price Update

Share PriceValue
Previous Day₹104.36

Basic Stock Data of Bal Pharma Ltd

Market Cap 166 Cr.
Current Price 105
High / Low118/63.4
Stock P/E51.7
Book Value 40.3
Dividend Yield0.97 %
ROCE9.56 %
ROE4.20 %
Face Value 10.0

Bal Pharma Ltd Quarterly Results


Bal Pharma Ltd Quarterly Chart

Bal Pharma Ltd Profit & Loss

MonthMar 2010Mar 2011Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023TTM
Operating Profit310181715151718525242527
OPM %3%9%10%9%7%6%8%8%3%10%9%8%9%
Other Income5111132121511
Profit before tax-1175333-0-144954
Tax %-57%60%23%25%90%114%87%1,175%5%-15%38%45%
Net Profit-10541-002-135632
EPS in Rs-1.360.394.562.821.101.241.962.67-8.623.203.781.641.50
Dividend Payout %0%0%22%35%91%81%51%37%0%31%26%61%

Bal Pharma Ltd Profit & Loss Yearly Chart

Bal Pharma Ltd Growth

Compounded Sales Growth
10 Years::%
5 Years::8%
3 Years::21%

Bal Pharma Ltd Growth

Compounded Profit Growth
10 Years::%
5 Years::47%
3 Years::30%

Bal Pharma Ltd Growth

Stock Price CAGR
10 Years::17%
5 Years::6%
3 Years::24%
1 Year::18%

Bal Pharma Ltd Growth

Return on Equity
10 Years::%
5 Years::1%
3 Years::7%
Last Year::4%

Bal Pharma Ltd Balance Sheet

MonthMar 2010Mar 2011Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Sep 2023
Equity Capital10101113131414141415151616
Other Liabilities3441566169788671687699116126
Total Liabilities124135155164211233260261238240261311330
Fixed Assets50485552566071707169677676
Other Assets748799111151172188187164172192235254
Total Assets124135155164211233260261238240261311330

Bal Pharma Ltd Reserves and Borrowings Chart

Bal Pharma Ltd Cash Flow

MonthMar 2010Mar 2011Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023
Cash from Operating Activity -551315-19618232227-2
Cash from Investing Activity 5-2-7-5-14-8-4-8-5-6-9-22
Cash from Financing Activity 1-2-8-732-640-20-17-1724
Net Cash Flow01-22-1-81-0-2000

Bal Pharma Ltd Financial Efficiency Indicators Chart

No valid data available for the Shareholding

Bal Pharma Ltd Shareholding Pattern Chart

No. of Bal Pharma Ltd Shareholders

This stock is not held by any mutual fund

Bal Pharma Ltd ROCE Trend

Bal Pharma Ltd EPS Trend

Bal Pharma Ltd Key Financial Ratios

MonthMar 23Mar 22Mar 21Mar 20Mar 19
Basic EPS (Rs.)1.673.793.34-9.101.52
Diluted EPS (Rs.)1.683.793.34-9.101.52
Cash EPS (Rs.)7.499.959.60-3.685.86
Book Value[Excl.RevalReserv]/Share (Rs.)40.6039.4635.9931.9942.49
Book Value[Incl.RevalReserv]/Share (Rs.)40.6039.4635.9931.9942.49
Revenue From Operations / Share (Rs.)193.89189.72169.02120.72158.77
PBDIT / Share (Rs.)16.6119.3117.274.6613.06
PBIT / Share (Rs.)10.7913.2110.85-0.758.72
PBT / Share (Rs.)
Net Profit / Share (Rs.)1.673.853.18-9.101.52
NP After MI And SOA / Share (Rs.)1.643.793.20-8.622.67
PBDIT Margin (%)8.5610.1810.213.858.22
PBIT Margin (%)5.566.966.41-0.625.49
PBT Margin (%)1.563.261.63-7.90-0.08
Net Profit Margin (%)0.862.021.88-7.530.95
NP After MI And SOA Margin (%)0.841.991.89-7.141.68
Return on Networth / Equity (%)4.039.578.85-23.305.68
Return on Capital Employeed (%)16.3020.6418.36-1.3612.60
Return On Assets (%)0.822.151.97-5.121.44
Long Term Debt / Equity (X)0.470.460.440.440.43
Total Debt / Equity (X)2.051.671.952.151.74
Asset Turnover Ratio (%)
Current Ratio (X)
Quick Ratio (X)0.620.660.680.580.68
Inventory Turnover Ratio (X)2.082.432.121.051.67
Dividend Payout Ratio (NP) (%)0.0026.410.00-11.590.00
Dividend Payout Ratio (CP) (%)0.0010.110.00-31.210.00
Earning Retention Ratio (%)0.0073.590.00111.590.00
Cash Earning Retention Ratio (%)0.0089.890.00131.210.00
Interest Coverage Ratio (%)2.142.752.140.531.47
Interest Coverage Ratio (Post Tax) (%)1.211.551.39-0.031.17
Enterprise Value (Cr.)228.31252.09180.34148.68205.00
EV / Net Operating Revenue (X)0.750.890.710.860.91
EV / EBITDA (X)8.768.817.0522.5311.07
MarketCap / Net Operating Revenue (X)0.340.560.310.260.44
Retention Ratios (%)0.0073.580.00111.590.00
Price / BV (X)1.652.731.490.871.50
Price / Net Operating Revenue (X)0.340.560.310.260.44

Bal Pharma Ltd Profitability Ratios (%)

Bal Pharma Ltd Liquidity Ratios

Bal Pharma Ltd Liquidity Ratios (%)

Bal Pharma Ltd Interest Coverage Ratios (%)

Bal Pharma Ltd Valuation Ratios

Fair Value of Bal Pharma Ltd Stock

Fair Value: ₹88.36

The stock is overvalued by 15.85% compared to the current price ₹105

*This is not Investment Advice

Strength and Weakness of Bal Pharma Ltd Stock

Unable to fetch valid data for stock valuation.